GLTO
Galecto Inc
NASDAQ: GLTO · HEALTHCARE · BIOTECHNOLOGY
$25.66
+7.23% today
Updated 2026-04-30
Market cap
$43.73M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-12.11
Dividend yield
—
52W range
$2 – $38
Volume
0.3M
Galecto Inc (GLTO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-1.10%
ROA
-0.44%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-15.87M | — | — | — |
| 2019 | $0.00 | $-38.42M | — | — | — |
| 2020 | $0.00 | $-34.84M | — | — | — |
| 2021 | $0.00 | $-51.75M | — | — | — |
| 2022 | $0.00 | $-61.62M | — | — | — |
| 2023 | $0.00 | $-38.35M | — | — | — |
| 2024 | $0.00 | $-21.44M | — | — | — |